Precision Therapeutics (POAI) Set to Announce Earnings on Monday
Precision Therapeutics (NASDAQ:POAI) is scheduled to announce its earnings results after the market closes on Monday, August 19th.
Precision Therapeutics (NASDAQ:POAI) last announced its earnings results on Wednesday, May 15th. The medical instruments supplier reported ($0.21) earnings per share (EPS) for the quarter. The business had revenue of $0.26 million for the quarter. Precision Therapeutics had a negative net margin of 925.08% and a negative return on equity of 714.98%.
Shares of NASDAQ POAI opened at $0.57 on Friday. The company has a debt-to-equity ratio of 3.68, a quick ratio of 0.71 and a current ratio of 0.77. Precision Therapeutics has a 12-month low of $0.40 and a 12-month high of $1.26.
Precision Therapeutics Company Profile
Predictive Oncology Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.
Recommended Story: SEC Filing
Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.